Clinical Trials Directory

Trials / Completed

CompletedNCT03158623

Wound Additives in Primary Total Joint Athroplasty

The Effects of Platelet-Rich Plasma and Activated Collagen on Wound Healing in Primary Total Joint Arthroplasty

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Salt Lake Orthopedic Clinic · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Accepted

Summary

3 cohorts of total joint patient of 30 members each were randomized to receive PRP or Activated Collegen or no additive were studied for status of the wound at 6 weeks and recorded all complications, infections and reoperations. The three groups were than compared for statistical analysis

Detailed description

Background: Wound healing remains a concern in primary total joint arthroplasty given the risk of deep infections arising from hematomas, wound separations, and superficial infections. If wound additives can prevent these early complications, their universal application would be cost effective. This study examined whether two wound additives, Platelet-Rich Plasma (PRP) and CellerateRX® (activated collagen), would improve postoperative wound healing and reduce complications in primary total joint arthroplasty. Methods: A prospective, randomized, controlled study using three cohorts with 30 patients each (Group 1: PRP, Group 2: activated collagen, Group 3: control) were examined postoperatively at two and six weeks, at which time the following data were recorded: six wound measurements, total postoperative blood loss, complications of superficial infections, and reoperations.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet Rich Plasma
BIOLOGICALCellerate

Timeline

Start date
2016-04-01
Primary completion
2016-12-06
Completion
2016-12-20
First posted
2017-05-18
Last updated
2017-05-18

Source: ClinicalTrials.gov record NCT03158623. Inclusion in this directory is not an endorsement.